Samlyn Capital’s SomaLogic, Inc. Warrant SLGCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-75,880
Closed -$162K 130
2022
Q1
$162K Hold
75,880
﹤0.01% 106
2021
Q4
$254K Buy
75,880
+425
+0.6% +$1.62K ﹤0.01% 113
2021
Q3
$261K Buy
75,455
+3,205
+4% +$9.88K ﹤0.01% 146
2021
Q2
$390K Buy
+72,250
New +$372K 0.01% 152

Other funds holding SLGCW

Samlyn Capital's SLGCW Position: Q2 2022 in Review

Samlyn Capital sold out of SomaLogic, Inc. Warrant (SLGCW) in Q2 2022, closing a stake of 75,880 shares — an estimated $162K sold.

Samlyn Capital first reported a position in SLGCW in Q2 2021 and held it in 4 quarters. The position peaked at $390K in Q2 2021. 28 funds tracked by Wall St. Rank hold SLGCW as of Q2 2022.

  • Samlyn Capital reported no remaining SomaLogic, Inc. Warrant position as of Q2 2022 after selling out during the quarter.
  • Samlyn Capital sold 75,880 SomaLogic, Inc. Warrant shares in Q2 2022, an estimated $162K.
  • Samlyn Capital first reported a position in SomaLogic, Inc. Warrant in Q2 2021 and held it in 4 quarters.
  • Samlyn Capital's SomaLogic, Inc. Warrant position peaked at $390K in Q2 2021.
  • 28 funds tracked by Wall St. Rank held SomaLogic, Inc. Warrant as of Q2 2022.

Based on Samlyn Capital's 13F filing for Q2 2022, filed 15 Aug 2022.